CME Stock Target Price and Analyst Consensus

CME Stock  USD 215.60  2.72  1.28%   
The current analyst and expert consensus on CME is Buy with 7 hold recommendations. The current projected CME target price consensus is 224.79 with 17 analyst opinions. One of the most common ways CME Group analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to CME vendors, executives, and/or customers. CME recommendation module provides expert sentiment on the projected CME Group target price to derive its highest and lowest estimates based on target price standard deviation of 0.0. Check out Macroaxis Advice on CME to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast
204.56
Highest Forecast
249.52
Target Price
224.79
The current year's Gross Profit Margin is expected to grow to 0.92, whereas Gross Profit is forecasted to decline to about 2.5 B. At present, CME's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 98.1 B, whereas Total Stockholder Equity is forecasted to decline to about 17.6 B.
  
It's important to approach CME's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

CME Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. CME target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. CME's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   17  Buy
Most CME analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand CME stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of CME Group, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

CME Target Price Projection

CME's current and average target prices are 215.60 and 224.79, respectively. The current price of CME is the price at which CME Group is currently trading. On the other hand, CME's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

CME Market Quote on 28th of March 2024

Low Price212.53Odds
High Price215.65Odds

215.6

Target Price

Analyst Consensus On CME Target Price

Low Estimate204.56Odds
High Estimate249.52Odds

224.79

Historical Lowest Forecast  204.56 Target Price  224.79 Highest Forecast  249.52
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on CME Group and the information provided on this page.

CME Analyst Ratings

CME's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about CME stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of CME's financials, market performance, and future outlook by experienced professionals. CME's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize CME price targets

CME's stock target price is an estimate of its future price, usually made by analysts. Using CME's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at CME's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if CME's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional CME Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of CME is a key component of CME valuation and have some predictive power on the future returns of a CME.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CME's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
214.42215.55216.68
Details
Intrinsic
Valuation
LowRealHigh
194.04218.23219.36
Details
Naive
Forecast
LowNextHigh
210.33211.46212.59
Details
Earnings
Estimates (0)
LowProjected EPSHigh
2.352.452.55
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as CME. Your research has to be compared to or analyzed against CME's peers to derive any actionable benefits. When done correctly, CME's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in CME Group.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Disruptive Technologies Idea
Disruptive Technologies
Invested few shares
Cash Cows Idea
Cash Cows
Invested a lot of shares
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Business Services Idea
Business Services
Invested few shares
FinTech Idea
FinTech
Invested over 40 shares
ESG Investing Idea
ESG Investing
Invested few shares
When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:
Check out Macroaxis Advice on CME to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for CME Stock analysis

When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Fundamental Analysis
View fundamental data based on most recent published financial statements
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
The data published in CME's official financial statements usually reflect CME's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of CME Group. For example, before you start analyzing numbers published by CME accountants, it's critical to develop an understanding of what CME's liquidity, profitability, and earnings quality are in the context of the Capital Markets space in which it operates.
Please note, the presentation of CME's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CME's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in CME's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CME Group. Please utilize our Beneish M Score to check the likelihood of CME's management manipulating its earnings.